Purpose
The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological instrument aims to evaluate the cognitive functioning in individuals with Alzheimer’s disease. This instrument consists of seven assessments: clinical battery, neuropsychology battery, neuropathology battery, neuroimaging battery, behavior rating scale for dementia, family history assessment, and services assessment.
Link to Instrument
Area of Assessment
Mental FunctionsExecutive Functioning
Activities & Participation
Cognition
Sensation & Pain
Assessment Type
Performance MeasureAdministration Mode
Paper & PencilCost
Not FreeActual Cost
$600.00Cost Description
Assessments can be purchased individually. Costs vary by assessment type:• Clinical/Neuropsychological: $70
• Neuropsychological Battery: $75
• Behavior Rating Scale for Dementia: $75
• CERAD Neuropathological Guide and Assessment for Alzheimer’s Disease: $90
• The Behavior Rating Scale for Dementia: $25
• Assessment of Service Needs of Patients with Dementia: $25